首页|肺癌化疗后肺部感染病原菌的分布及血清细胞角蛋白19片段抗原、高迁移率族蛋白B1及可溶性血红蛋白清道夫受体的诊断价值

肺癌化疗后肺部感染病原菌的分布及血清细胞角蛋白19片段抗原、高迁移率族蛋白B1及可溶性血红蛋白清道夫受体的诊断价值

扫码查看
目的 探讨肺癌化疗后肺部感染病原菌分布及血清细胞角蛋白19片段抗原(CYFRA21-1)、高迁移率族蛋白B1(HMGB1)、可溶性血红蛋白清道夫受体(sCD163)水平变化和诊断价值。方法 将2022年7月—2023年11月收治的83例肺癌化疗患者根据肺部感染情况分为未感染组(n=43)和感染组(n=40)。收集肺癌化疗患者痰液标本,记录标本来源并进行菌种鉴定。比较2组血清CYFRA21-1、HMGB1、sCD163水平变化;采用多因素Logistic回归模型分析肺癌化疗后肺部感染的影响因素;分析血清CYFRA21-1、HMGB1、sCD163水平对肺癌化疗后肺部感染的诊断价值。结果 80例肺癌化疗患者中,发生肺部感染者40例;病原菌检测出55株,其中革兰阴性菌、革兰阳性菌分别为34、18株,占比61。82%、32。73%,真菌仅3株,占比5。45%。感染组血清CYFRA21-1、HMGB1、sCD163水平均高于未感染组,差异有统计学意义(P<0。05)。年龄、肺部疾病史、CYFRA21-1、HMGB1、sCD163为肺癌化疗患者发生肺部感染的影响因素(P<0。05)。血清CYFRA21-1、sCD163、HMGB1水平诊断肺癌化疗后肺部感染的曲线下面积依次为0。677、0。763、0。819(P<0。05)。结论 肺癌化疗后,肺部感染患者病原菌以革兰阴性菌为主,血清CYFRA21-1、HMGB1、sCD163水平显著升高,其可作为早期诊断和评估感染的生物学指标。
Distribution of pulmonary infection pathogens after lung cancer chemotherapy and diagnostic values of serum cytokeratin 19 fragment antigen,high mobility group box 1 protein and soluble hemoglobin scavenger receptor
Objective To investigate the distribution of pathogens causing pulmonary infection af-ter lung cancer chemotherapy and the changes and diagnostic value of serum cytokeratin 19 fragment antigen(CYFRA21-1),high mobility group box 1 protein(HMGB1),and soluble hemoglobin scav-enger receptor(sCD163)levels.Methods A total of 83 lung cancer patients with chemotherapy from July 2022 to November 2023 were divided into non-infected group(n=43)and infected group(n=40)based on their pulmonary infection status,sputum samples were collected from lung cancer chemo-therapy patients,and the source of the samples was recorded for bacterial identification.The changes in serum CYFRA21-1,HMGB1 and sCD163 levels were compared between the two groups;a multiva-riate Logistic regression model was used to analyze the factors influencing pulmonary infection after lung cancer chemotherapy;the diagnostic values of serum CYFRA21-1,HMGB1 and sCD163 levels for pulmonary infection after lung cancer chemotherapy were analyzed.Results Among the 83 patients with lung cancer chemotherapy,40 cases had pulmonary infections;a total of 55 strains of pathogens were detected,including 34 Gram-negative bacteria and 18 Gram-positive bacteria,accounting for 61.82%and 32.73%respectively,while only 3 strains of fungi were detected,accounting for 5.45%.Serum levels of CYFRA21-1,HMGB1 and sCD163 in the infected group were significantly higher than those in the non-infected group(P<0.05).Age,history of lung diseases,CYFRA21-1,HMGB1 and sCD163 were factors influencing pulmonary infection in patients with lung cancer chem-otherapy(P<0.05).The areas under the curve for the diagnostic value of serum CYFRA21-1,sCD163 and HMGB1 levels for pulmonary infection after lung cancer chemotherapy were 0.677,0.763 and 0.819,respectively(P<0.05).Conclusion The main pathogens causing pulmonary infection after lung cancer chemotherapy are Gram-negative bacteria,and the serum levels of CYFRA21-1,HMGB1 and sCD163 increase significantly,which can be used as biological indicators for early diagnosis and assessment of infection.

lung cancerchemotherapypulmonary infectionpathogenscytokeratin 19 fragment antigenhigh mobility group box 1 proteinsoluble hemoglobin scavenger receptor

郑钧麒、刘相燕

展开 >

山东大学齐鲁医学院,山东济南,250012

肺癌 化疗 肺部感染 病原菌 细胞角蛋白19片段抗原 高迁移率族蛋白B1 可溶性血红蛋白清道夫受体

山东省自然科学基金资助项目

ZR2020MH244

2024

实用临床医药杂志
扬州大学,中国高校科技期刊研究会

实用临床医药杂志

CSTPCD
影响因子:1.543
ISSN:1672-2353
年,卷(期):2024.28(14)
  • 19